Antibody Selection from Immunoglobulin Libraries Expressed in Mammalian Cells

Therapeutic Monoclonal Antibodies: From Bench to Clinic

Volumn , Issue , 2009, Pages 283-307

  Smith, Ernest S ^a   Zauderer, Maurice ^a  

^a VACCINEX INC   (United States)

Author keywords

Antibody selection from immunoglobulin libraries expressed in mammalian cells; Antibody selection in secreted IgG format; Membrane antibody platform

Indexed keywords

EID: 79953216201     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470485408.ch12     Document Type: Chapter

References (41)

1. Adams, G.P., and L.M. Weiner. 2005. Monoclonal antibody therapy of cancer. Nature Biotechnol. 23(9):1147-1157.
2. Baixeras, E., A. Cebrian, J.P. Albar, et al. 1998. Vaccinia virus-induced apoptosis in immature B lymphocytes: Role of cellular Bcl-2. Virus Res. 58(1-2):107-113.
3. Bataille, R., B. Barlogie, Z.Y. Lu, et al. 1995. Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood 86(2):685-691.
4. de Haard, H.J., N. van Neer, A. Reurs, et al. 1999. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J. Biol. Chem. 274(26):18218-18230.
5. Evans, E.E., A.D. Henn, A. Jonason, et al. 2006. 35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Mol. Cancer Ther. 5(11):2919-2930.
6. Feldhaus, M.J., R.W. Siegel, L.K. Opresko, et al. 2003. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nature Biotechnol. 21(2):163-170.
7. Flower, D.R. 1999. Modelling G-protein-coupled receptors for drug design. Biochim. Biophys. Acta 1422(3): 207-234.
8. Gabay, C. 2006. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8(Suppl 2):S3.
9. Green, L.L. 1999. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J. Immunol. Methods 231(1-2):11-23.
10. Haddad, E., S. Paczesny, V. Leblond, et al. 2001. Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: A multicenter phase 1-2 clinical trial. Blood 97(6):1590-1597.
11. Hoogenboom, H.R. 2005. Selecting and screening recombinant antibody libraries. Nature Biotechnol. 23(9):1105-1116.
12. Jones, P.T., P.H. Dear, J. Foote, M.S. Neuberger, and G. Winter. 1986. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321(6069):522-525.
13. Klein, B., J. Wijdenes, X.G. Zhang, et al. 1991. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 78(5):1198-1204.
14. Knappik, A., L. Ge, A. Honegger, et al. 2000. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J. Mol. Biol. 296(1):57-86.
15. Lipsky, P.E. 2006. Interleukin-6 and rheumatic diseases. Arthritis Res. Ther. 8(Suppl 2):S4.
16. Liu, A.Y., R.R. Robinson, E.D. Murray, Jr., J.A. Ledbetter, I. Hellstrom, and K.E. Hellstrom. 1987. Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fc-dependent biologic activity. J. Immunol. 139(10):3521-3526.
17. Lonberg, N. 2005. Human antibodies from transgenic animals. Nature Biotechnol. 23(9):1117-1125.
18. Marks, J.D., H.R. Hoogenboom, T.P. Bonnert, J. McCafferty, A.D. Griffiths, and G. Winter. 1991. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222(3):581-597.
19. Mazor, Y., T. Van Blarcom, R. Mabry, B.L. Iverson, and G. Georgiou. 2007. Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nature Biotechnol. 25(5):563-565.
20. Merchant, A.M., Z. Zhu, J.Q. Yuan, et al. 1998. An efficient route to human bispecific IgG. Nature Biotechnol. 16(7):677-681.
21. Merchlinsky, M., D. Eckert, E. Smith, and M. Zauderer. 1997. Construction and characterization of vaccinia direct ligation vectors. Virology 238(2):444-451.
22. Morrison, S.L., M.J. Johnson, L.A. Herzenberg, and V.T. Oi. 1984. Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains. Proc. Natl. Acad. Sci. USA 81(21):6851-6855.
23. Moss, B. 1991. Vaccinia virus: A tool for research and vaccine development. Science 252(5013):1662-1667.
24. Nambi, P., and N. Aiyar. 2003. G protein-coupled receptors in drug discovery. Assay Drug Dev. Technol. 1(2):305-310.
25. Nissim, A., H.R. Hoogenboom, I.M. Tomlinson, et al. 1994. Antibody fragments from a "single pot" phage display library as immunochemical reagents. EMBO J. 13(3):692-698.
26. Osbourn, J., M. Groves, and T. Vaughan. 2005. From rodent reagents to human therapeutics using antibody guided selection. Methods 36(1):61-68.
27. Queen, C., W.P. Schneider, H.E. Selick, et al. 1989. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA 86(24):10029-10033.
28. Ramsey-Ewing, A., and B. Moss. 1996. Recombinant protein synthesis in Chinese hamster ovary cells using a vaccinia virus/bacteriophage T7 hybrid expression system. J. Biol. Chem. 271(28):16962-16966.
29. Reichert, J.M., C.J. Rosensweig, L.B. Faden, and M.C. Dewitz. 2005. Monoclonal antibody successes in the clinic. Nature Biotechnol. 23(9):1073-1078.
30. 2 of melphalan in multiple myeloma: Results of a pilot study including biological aspects. Bone Marrow Transplant. 36(9):771-779.
31. Scheiflinger, F., F. Dorner, and F.G. Falkner. 1992. Construction of chimeric vaccinia viruses by molecular cloning and packaging. Proc. Natl. Acad. Sci. USA 89(21):9977-9981.
32. Sheets, M.D., P. Amersdorfer, R. Finnern, et al. 1998. Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens. Proc. Natl. Acad. Sci. USA 95(11):6157-6162.
33. Smith, E.S., A. Mandokhot, E.E. Evans, et al. 2001. Lethality-based selection of recombinant genes in mammalian cells: Application to identifying tumor antigens. Nature Med. 7(8):967-972.
34. Smith, E.S., S. Shi, and M. Zauderer. 2004. Construction of cDNA libraries in vaccinia virus. Methods Mol. Biol. 269:65-76.
35. Smolen, J.S., and R.N. Maini. 2006. Interleukin-6: A new therapeutic target. Arthritis Res. Ther. 8(Suppl 2):S5.
36. Somogyi, P., J. Frazier, and M.A. Skinner. 1993. Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells. Virology 197(1):439-444.
37. Tsung, K., J.H. Yim, W. Marti, R.M. Buller, and J.A. Norton. 1996. Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J. Virol. 70(1):165-171.
38. Tsurushita, N., and M. Vasquez. 2003. Humanization of monoclonal antibodies. In: T. Honjo, F.W. Alt, and M. Neuberger (eds), Molecular Biology of B Cells, Academic press. 533-546.
39. Van den Buecken, T., H. Pieters, M. Steukers, et al. 2003. Affinity maturation of Fab antibody fragments by fluorescent-activated cell sorting of yeast-displayed libraries. FEBS Lett. 546(2-3):288-294.
40. Vugmeyster, Y., J. Beyer, K. Howell, et al. 2005. Depletion of B cells by a humanized anti-CD20 antibody PR070769 in Macaca fascicularis. J. Immunother. 28(3):212-219.
41. Wijdenes, J., C. Clement, B. Klein, et al. 1991. Humanrecombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies. Mol. Immunol. 28(11):1183-1192.